$79.22
-1.37-1.70%
Last update: Jan 13, 10:27 AM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Virtus LifeSci Biotech Products ETF (BBP) Stock Price, Quote, News & History
BBPARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
44.91M
Fund Score
Key Statistics
Open
$79.22
High
$79.22
52 Wk High
$82.80
AUM
44.91M
Dividend
-
Ex-Div Date
-
Volume
916
Market Cap
$15.72B
Mgmt Fee
0.79%
P/E Ratio
16.20
Prev. Close
$80.59
Low
$79.22
52 Wk Low
$48.65
Shares Out
350.00K
Yield
-
Div. Freq
-
Avg. Volume Daily
8.53K
Beta
0.58
Avg. Expense Ratio
0.79%
P/B Ratio
3.67
Recent Virtus LifeSci Biotech Products ETF News
FAQ
Q
How do I buy Virtus LifeSci Biotech Products ETF (BBP) stock?
A
You can purchase shares of Virtus LifeSci Biotech Products ETF (ARCA:BBP) through any online brokerage.
Q
Who are Virtus LifeSci Biotech Products ETF (BBP) competitors?
A
There are no as such competitors for Virtus LifeSci Biotech Products ETF.
Q
What is the forecast, or price target, for Virtus LifeSci Biotech Products ETF (BBP) stock?
A
There is no analysis for Virtus LifeSci Biotech Products ETF to provide a consensus price target.
Q
What is the current price for Virtus LifeSci Biotech Products ETF (BBP)?
A
The stock price for Virtus LifeSci Biotech Products ETF (ARCA: BBP) is $79.22 last updated January 13, 2026 at 10:27 AM EST.
Q
Does Virtus LifeSci Biotech Products ETF (BBP) pay a dividend?
A
There are no upcoming dividends for Virtus LifeSci Biotech Products ETF.
Q
When is Virtus LifeSci Biotech Products ETF (ARCA:BBP) reporting earnings?
A
Virtus LifeSci Biotech Products ETF does not have any upcoming earnings scheduled.
Q
Is Virtus LifeSci Biotech Products ETF (BBP) going to split?
A
There is no upcoming split for Virtus LifeSci Biotech Products ETF.
Key Statistics
Open
$79.22
High
$79.22
52 Wk High
$82.80
AUM
44.91M
Dividend
-
Ex-Div Date
-
Volume
916
Market Cap
$15.72B
Mgmt Fee
0.79%
P/E Ratio
16.20
Prev. Close
$80.59
Low
$79.22
52 Wk Low
$48.65
Shares Out
350.00K
Yield
-
Div. Freq
-
Avg. Volume Daily
8.53K
Beta
0.58
Avg. Expense Ratio
0.79%
P/B Ratio
3.67
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Dec 16, 2014 |
| Managers | Seth Kadushin Paul Yook Andrew McDonald Matthew B. Brown |
| Definition | This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential |
Investment Policy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| INSM | Insmed Inc | 3.07% |
| TARS | Tarsus Pharmaceuticals... | 2.79% |
| BBIO | Bridgebio Pharma Llc | 2.59% |
| IONS | Ionis Pharmaceuticals ... | 3.28% |
| CA | Aurinia Pharmaceutical... | 2.78% |
| LGND | Ligand Pharmaceuticals... | 2.45% |
| MDGL | Madrigal Pharmaceutica... | 2.77% |
| TVTX | Travere Therapeutics I... | 3.27% |
| ROIV | Roivant Sciences Ltd | 2.52% |
| TBPH | Theravance Biopharma I... | 2.50% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved